文献速递咽喉与嗓音

脂肪注射治疗单侧声带麻痹:系统综述与Meta分析

Lipoinjection for Unilateral Vocal Fold Paralysis Treatment: A Systematic Review and Meta-Analysis.
PubMed 文献 · Laryngoscope · 2021-12-11

该系统综述与Meta分析纳入49篇文献、1166例患者,评估脂肪注射治疗单侧声带麻痹的可预测性及不同技术的安全性和疗效差异。脂肪注射平均用量1.3 mL(95%CI 0.92–1.69),平均过度矫正30%;术后6个月嗓音参数(最长发声时间、Jitter、Shimmer、GRBAS各分项、VHI-30)较术前显著改善,不同脂肪获取技术间无统计学显著差异,并发症少,仅86例需再次干预。结论认为脂肪注射似乎是单侧声带麻痹的安全治疗选择,疗效可持续6个月至1年。

要点

  • 脂肪注射平均用量1.3 mL(95%CI 0.92–1.69),平均过度矫正30%。
  • 术后6个月最长发声时间、Jitter、Shimmer、GRBAS分项及VHI-30均较术前显著改善。
  • 不同脂肪获取技术间疗效无统计学显著差异,并发症少,仅86例需再次干预。

核心结论

  • 脂肪注射似乎是单侧声带麻痹的安全治疗选择,现有数据显示疗效持续6个月至1年。

研究设计与样本

  • 系统综述与Meta分析,检索Medline、Cochrane和Scopus数据库,纳入49篇文献、分析1166例患者的数据。

主要发现

  • 脂肪注射平均用量1.3 mL,95%CI(0.92,1.69),平均过度矫正30%。
  • 术后6个月最长发声时间由术前5.12(95%CI 4.48–5.76)改善至10.46(95%CI 9.18–11.75)。
  • 术后6个月Jitter由术前2.71(95%CI 2.08–3.33)降至1.37(95%CI 1.05–1.70)。
  • 术后6个月Shimmer由术前4.55(95%CI 3.04–6.07)降至2.57(95%CI 1.69–3.45)。
  • 术后6个月GRBAS的grade、breathiness、asthenia及VHI-30均较术前改善,按脂肪获取技术亚组分析无统计学显著差异,并发症少,仅86例需再次干预。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Lipoinjection is one of the available treatments for unilateral vocal fold paralysis. OBJECTIVE: To evaluate lipoinjection predictability, and analyze the differences in safety and efficacy of the different techniques. STUDY DESIGN: Systematic review and meta-analysis. METHODS AND RESULTS: A systematic review on Medline, Cochrane, and Scopus databases included 49 articles analyzing the data of 1,166 patients, concerning technical details and voice parameters changes. Lipoinjection used a mean volume of 1.3 mL, 95% confidence interval (CI) (0.92, 1.69)-average overcorrection of 30%. Meta-analysis of pre- and postoperative voice parameters' means showed a significant improvement at 6 months of mean phonation time (preoperative: 5.12, 95% CI [4.48, 5.76]-6 months: 10.46, 95% CI [9.18, 11.75]), Jitter (preoperative: 2.71, 95% CI [2.08, 3.33])-6 months: 1.37, 95% CI [1.05, 1.70]), Shimmer (preoperative: 4.55, 95% CI [3.04, 6.07]-6 months: 2.57, 95% CI [1.69, 3.45]), grade (preoperative: 2.15, 95% CI [1.73, 2.57]-6 months: 0.12, 95% CI [0.97, 1.43]), breathiness (preoperative: 2.012, 95% CI [1.48, 2.55]-6 months: 0.99, 95% CI [0.58, 1.40]), and asthenia (preoperative: 1.90, 95% CI [1.33, 2.47]-6 months: 0.75, 95% CI [0.17, 1.33]) of GRBAS (Grade, Roughness, Breathiness, Asthenia and Strain), and Voice Handicap Index-30 (preoperative: 72.06, 95% CI [54.35, 89.76]-6 months: 26.24, 95% CI [19.58, 32.90]). Subgroup analysis by harvesting technique concluded in no statistically significant difference between them. Few complications were reported. Reintervention was only required for 86 patients. CONCLUSION: Lipoinjection seems a safe therapeutic option for unilateral vocal fold paralysis, with available data showing an efficacy lasting 6 months to 1 year. Laryngoscope, 132:1630-1640, 2022.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Haddad R, Ismail S, Khalaf MG, et al. Lipoinjection for Unilateral Vocal Fold Paralysis Treatment: A Systematic Review and Meta-Analysis. Laryngoscope. 2021. PMID: 34894158. doi:10.1002/lary.29965

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。